Skip to main content

Table 5 Effects of MAPT haplotype and disease status on levels of tau isoforms and α-syn in the insoluble protein fraction in human samples of fusiform gyrus and cerebellum

From: Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

Protein fraction

Brain region

Two-way ANOVA

Main effect of haplotype

Main effect of disease

Haplotype × disease

Direction of significant effect

P value

P value

P value

P value

α-syn

ctx-fg

0.134

0.781

0.026

0.995

PD > Control

 

ctx-cbl

0.953

0.628

0.767

0.875

–

Total tau

ctx-fg

0.150

0.243

0.099

0.587

–

 

ctx-cbl

0.576

0.580

0.590

0.229

–

0N3R tau

ctx-fg

0.108

0.252

0.036

0.881

PD > Control

 

ctx-cbl

0.226

0.301

0.080

0.669

–

0N4R tau

ctx-fg

0.215

0.453

0.098

0.554

–

 

ctx-cbl

0.371

0.380

0.145

0.469

–

1N3R tau

ctx-fg

0.362

0.491

0.130

0.889

–

 

ctx-cbl

0.385

0.226

0.298

0.375

–

1N4R tau

ctx-fg

0.031

0.062

0.043

0.289

PD > Control

 

ctx-fg

0.616

0.779

0.199

0.643

–

2N3R tau

ctx-cbl

0.596

0.790

0.303

0.535

–

 

ctx-fg

0.966

0.626

0.939

0.992

–

2N4R tau

ctx-cbl

0.564

0.395

0.605

0.287

–

 

ctx-fg

0.299

0.079

0.803

0.651

–

  1. Bold values indicate a significant result with P < 0.05
  2. Main effect of haplotype was analyzed by comparison of H1/H1 (Controls + PD) versus H2/H2 (Controls + PD). Main effect of disease was analyzed by comparison of PD (H1/H1 + H2/H2) versus Controls (H1/H1 + H2/H2). The interaction haplotype × disease examined the relationship between the independent variables (haplotype + disease) on the dependent variable of protein levels. P values were calculated using two-way ANOVA followed by Tukey’s multiple comparisons test
  3. ctx-fg, cortex of fusiform gyrus; ctx-cbl, cerebellum.